Startups
Epsilogen
https://epsilogen.com/Developer of immunoglobulin E (IgE) antibodies to treat cancer.
Summary
Industry
Total Funding
$64.5M
- Series B (2024-09-09) $16.5M
- Unknown (2022-01-01) $41.7M
- Series A (2018-11-30) $6.3M
Investors
ALSA Ventures Series B
Novartis Venture Fund Series B
Epidarex Capital Series B
British Patient Capital Series B
3B Future Health Fund Series B
AlbionVC Series A
Full Company Profile
- Access details of the company management, and other intelligence on this company by registering for Seedtable